TILT Biotherapeutics raised $25.6M to find a cure for ovarian cancer - Tech Funding News
Funding & venture capital News
Today, TILT Biotherapeutics announced a $25.6 million Series B funding round led by existing investors, including the European Innovation Council (EIC) ...
